KRAS and lung adenocarcinoma: Furthermore, whereas KRASG12C is the most frequent KRAS mutation in lung adenocarcinomas in current/former-smokers, it is approximately three times less prevalent in never-smokers in which KRASG12D is the dominant mutation (Supplementary Fig. 16b and Supplementary Data 6)45,58,59.